Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

CABERGOLINE CRS (170 MG)

CABERGOLINE CRS (170 MG)

81409-90-7

DISCOVER
CALCIPOTRIOL MONOHYDRATE CRS (10 MG)

CALCIPOTRIOL MONOHYDRATE CRS (10 MG)

147657-22-5

DISCOVER
CALCIPOTRIOL MONOHYDRATE - REFERENCE SPECTRUM (N/A)

CALCIPOTRIOL MONOHYDRATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
CARBOPROST TROMETAMOL CRS (40MG)

CARBOPROST TROMETAMOL CRS (40MG)

58551-69-2

DISCOVER
CHLORDIAZEPOXIDE IMPURITY A CRS (15 MG)

CHLORDIAZEPOXIDE IMPURITY A CRS (15 MG)

NA

DISCOVER
GRANISETRON IMPURITY A CRS (1MG)

GRANISETRON IMPURITY A CRS (1MG)

NA

DISCOVER
GRANISETRON IMPURITY B CRS (1MG)

GRANISETRON IMPURITY B CRS (1MG)

NA

DISCOVER
CHLORPROMAZINE IMPURITY D CRS(15 MG)

CHLORPROMAZINE IMPURITY D CRS(15 MG)

NA

DISCOVER
DIBROMPROPAMIDINE DIISETIONATE CRS (10 MG)

DIBROMPROPAMIDINE DIISETIONATE CRS (10 MG)

614-87-9

DISCOVER
DIBROMPROPAMIDINE FOR SYSTEM SUITABILITY CRS (20 MG)

DIBROMPROPAMIDINE FOR SYSTEM SUITABILITY CRS (20 MG)

614-87-9

DISCOVER
DIHYDROTACHYSTEROL FOR SYSTEMSUITABILITY CRS (5 MG)

DIHYDROTACHYSTEROL FOR SYSTEMSUITABILITY CRS (5 MG)

67-96-9

DISCOVER
HYOSCINE CRS (15 MG)

HYOSCINE CRS (15 MG)

51-34-3

DISCOVER